Bayesian Capital Management, LP - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 745 filers reported holding GLAXOSMITHKLINE PLC in Q3 2016. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q1 2021$1,243,000
+310.2%
34,825
+398.9%
0.29%
+58.0%
Q2 2016$303,000
+31.2%
6,980
+22.7%
0.18%
-17.0%
Q1 2016$231,000
-22.2%
5,690
-22.8%
0.22%
-48.8%
Q4 2015$297,0007,3710.43%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2016
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders